Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2020-12-03 2020-12-03 129512
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2021-02-05 2021-03-04 133441
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-02-16 2023-04-28 184919
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-12 2023-12-07 206904
TEVA-METHYLPHENIDATE ER-C 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30668
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
TEVA-ATOMOXETINE 18MG CAPSULE Resolved 2020-04-02 2021-04-15 110670
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2017-03-13 2020-02-13 1697
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2017-03-13 2021-09-23 1714
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-18 2019-07-15 86972
CEFOXITIN FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-06-27 2020-02-07 87662
TEVA-SUCRALFATE 1G TABLET Resolved 2019-08-29 2020-01-30 92663
CEFAZOLIN FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2019-09-26 2019-10-10 94837
TEVA-TRYPTOPHAN 1G TABLET Resolved 2020-02-07 2020-03-26 105564
TEVA-SUCRALFATE 1G TABLET Resolved 2020-03-26 2020-08-21 109595
TEVA-SUCRALFATE 1G TABLET Resolved 2020-07-23 2020-08-21 120890
TEVA-SUCRALFATE 1G TABLET Resolved 2020-09-24 2020-10-15 124995
CEFTRIAXONE SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Resolved 2021-01-07 2021-02-12 131093
TEVA-SUCRALFATE 1G TABLET Resolved 2021-04-01 2021-04-08 136759

Showing 901 to 920 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250